Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Scientific Reports|November 9, 2022
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohortNoemi F Freise, Smaranda Gliga, Johannes Fischer, et al.European Journal of Medical Research|June 25, 2020
The history and value of face masksChristiane Matuschek, Friedrich Moll, Heiner Fangerau, et al.European Journal of Medical Research|August 14, 2020
Face masks: benefits and risks during the COVID-19 crisisChristiane Matuschek, Friedrich Moll, Heiner Fangerau, et al.Artificial Intelligence in the Life Sciences|January 6, 2022
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe CasesThomas Linden, Frank Hanses, Daniel Domingo-Fernández, et al.Artificial Intelligence in the Life Sciences|February 14, 2022
Corrigendum to "Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases"[Artificial Intelligence in Life Sciences] 1(2021), 100020Thomas Linden, Frank Hanses, Daniel Domingo-Fernández, et al.European Journal of Medical Research|February 9, 2023
Percutaneous fractionated radiotherapy of the groin to eliminate lymphatic fistulas after vascular surgeryDanny Jazmati, Bálint Tamaskovics, Norman-Philipp Hoff, et al.Trials|May 18, 2021
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trialVerena Keitel, Björn Jensen, Torsten Feldt, et al.Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.Scientific Reports|November 10, 2023
Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessmentsCarolin Balloff, Carolina Bandlow, Michael Bernhard, et al.European Journal of Medical Research|August 7, 2021
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testingJohannes C Fischer, Albrecht G Schmidt, Edwin Bölke, et al.Pageof 13